HomePeopleFeedbackContents

Edward M. Bednarczyk, Pharm.D.

Clinical Associate Professor
Director of Research
(716) 838-5889

eb@buffalo.edu

http://www.nucmed.buffalo.ed/ed/

To view my profile on the COS http://myprofile.cos.com/bednarce68

   

Recent Publications

Zubeldia JM,  Bednarczyk EM, Baker JG, Nabi AH. The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases. Cancer Biotherapy and Radiopharmaceuticals 2005;20(4):450.56.

Edwards, KR, Hershey, L, Wray, L, Bednarczyk, EM, Lichter, D, Farlow, M, Johnson, S. Efficacy and safety of galatamine in patients with dementia with Lewy bodies: a 12-week interim analysis. Dement Geriatr Cogn Disord 2004;17 (suppl 1):40-48.

Guarasci DT, Trinh L, Baeumler GR, Bednarczyk, EM. Case Report: Comparison of compounded sincalide and Kinevac in the evaluation of gallbladder ejection fraction. Annals of Pharmacotherapy2004;38:428-32.

Bednarczyk, EM, Mayer D, Wong LK. Nuclear Pharmacy Education in ACPE-Accredited Colleges of Pharmacy. J Pharm Edu 2004;68(1):article 6.

Bednarczyk EM, Murphy B, Wack DS, Burch K, Trinidad K. Brain Blood Flow in the Nitroglycerin (GTN) Model of Migraine: Measurement Using Positron Emission Tomography and Transcranial Doppler. Cephalalgia 2002;22(9):749-57.


   
   

 

Send mail to: webmaster@nucmed.buffalo.edu with questions or comments about this web site.


Last updated: November 11, 2005